11 Menopause Myths That Wellness Influencers Keep Spreading — and What the Clinical Evidence Actually Shows
The thing that haunts me about this topic is how many women spend two or three years doing seed cycling and "liver cleanses" while their bone density quietly drops and their sleep quietly unravels. That delay has real consequences. Getting curious about the evidence isn't about being anti-wellness — it's about making sure the time and money spent is actually moving the needle.
Learn more about Rose →Myth: Seed cycling balances hormones during perimenopause
Seed cycling — eating specific seeds in the first and second halves of a monthly cycle — is widely promoted on social media as a way to regulate estrogen and progesterone naturally. There are no published clinical trials testing seed cycling in perimenopausal or postmenopausal women, and no established physiological mechanism by which rotating flaxseeds and pumpkin seeds could meaningfully shift reproductive hormone levels. Flaxseeds do contain lignans with weak phytoestrogenic activity, but the effect size in studies of menopausal symptoms is modest at best and the seed cycling protocol itself has never been tested.
Myth: The body needs to 'detox' excess estrogen through the liver and gut
The "estrogen detox" narrative — usually sold alongside DIM supplements, cruciferous vegetable protocols, and specific probiotics — frames perimenopause as a problem of estrogen excess that the liver is failing to clear. In reality, the defining hormonal feature of perimenopause is erratic and ultimately declining estrogen, not accumulation. The liver does metabolize estrogen via well-understood pathways, and gut health does influence estrogen recirculation through the estrobolome, but there is no clinical evidence that "detox" protocols correct menopausal symptoms or that most symptomatic women have impaired estrogen clearance.
Myth: Adrenal fatigue is the real driver of perimenopause symptoms
"Adrenal fatigue" — the idea that chronically stressed adrenal glands become exhausted and unable to produce hormones — is not a recognised medical diagnosis and has been reviewed and rejected as a clinical entity in published literature, including a 2016 systematic review in BMC Endocrine Disorders that found no consistent evidence for the condition. The adrenal glands do produce a small amount of estrogen precursors after menopause, and HPA axis dysregulation is a real phenomenon in chronic stress, but the "adrenal fatigue" framing is used to sell extensive supplement protocols in place of evidence-based treatment. Women experiencing fatigue, brain fog, and low mood in perimenopause deserve an evaluation of their actual hormone levels, thyroid function, and sleep quality.
Myth: Bioidentical hormones from compounding pharmacies are safer than regulated HRT
Compounded "bioidentical" hormone preparations are heavily marketed as a natural, safer alternative to pharmaceutical hormone therapy, but the claim does not hold up to scrutiny. Regulated HRT formulations — including many that are molecularly identical to human hormones — have been through rigorous safety and efficacy testing, while compounded preparations have not been evaluated for consistent dosing, sterility, or long-term safety. The Endocrine Society and the British Menopause Society both state that there is no evidence compounded bioidenticals are safer or more effective than regulated hormone therapy, and inconsistent dosing carries its own risks.
Myth: Progesterone cream is an effective alternative to oral or body-identical progesterone
Over-the-counter progesterone creams are sold as a gentler, more natural way to top up progesterone during perimenopause, but the evidence shows they do not adequately protect the uterine lining in women who still have a uterus and are taking estrogen. Transdermal progesterone from creams has poor and unpredictable absorption compared to regulated body-identical progesterone such as micronised progesterone, and plasma levels achieved are generally insufficient for endometrial protection. Women using estrogen therapy who have a uterus must use a properly dosed, regulated progestogen — using a cream instead creates a genuine clinical risk.
Myth: Cortisol testing via saliva or urine tells you everything you need to know about your hormones
Functional medicine and wellness practitioners frequently offer multi-point salivary cortisol testing alongside comprehensive hormone panels as a way to map a woman's hormonal landscape — and the tests are often sold directly alongside the results. While salivary cortisol testing has legitimate research applications, its clinical utility for guiding treatment in perimenopausal women outside of diagnosing Addison's or Cushing's disease is not established. The results of these tests are frequently used to recommend extensive supplement regimens rather than address the underlying hormonal changes that evidence-based treatment actually targets.
Myth: A healthy diet and exercise can fully replace hormone therapy for managing menopause
Lifestyle interventions — quality sleep, resistance training, a Mediterranean-style diet, reducing alcohol — have genuine, evidence-backed benefits for menopausal women and should be part of any approach to this life stage. However, the claim that lifestyle changes alone can replicate the effects of hormone therapy for women with significant vasomotor symptoms, genitourinary syndrome, or accelerated bone loss is not supported by the evidence. A 2023 Menopause Society position statement reaffirmed that for healthy women under 60 or within ten years of menopause onset, the benefits of hormone therapy for symptom relief and bone protection outweigh the risks for most — and no lifestyle protocol achieves the same outcomes.
Myth: Black cohosh is a well-evidenced herbal treatment for hot flushes
Black cohosh is one of the most widely recommended herbal supplements for hot flushes, and its popularity is sometimes presented as evidence of efficacy. The clinical trial data is actually mixed and inconsistent — some small trials show modest benefit over placebo, but larger, better-designed studies have not confirmed meaningful relief, and a 2012 Cochrane review found insufficient evidence to support its use. There are also documented cases of hepatotoxicity associated with black cohosh supplements, which is a meaningful safety consideration when the efficacy evidence is weak.
Myth: Estrogen dominance causes most perimenopausal symptoms
"Estrogen dominance" is a popular wellness concept describing a state where estrogen is high relative to progesterone, and it is frequently invoked to explain virtually every perimenopausal symptom from mood swings to weight gain to insomnia. While the relative decline in progesterone can precede the decline in estrogen in early perimenopause — producing a genuine shift in the estrogen-to-progesterone ratio — the concept as used in wellness spaces is loosely defined, rarely measured, and used to justify supplement and dietary protocols with no clinical trial support. Many women labelled with "estrogen dominance" by wellness practitioners actually have low estrogen, and treating them as if they have excess makes their situation worse.
Myth: Hormone therapy causes breast cancer, so natural alternatives are always the safer choice
The fear of breast cancer is the single most powerful reason women decline hormone therapy, and it has been significantly amplified by a misreading of the original 2002 Women's Health Initiative study — a study that used oral conjugated equine estrogen combined with medroxyprogesterone acetate in older women, not the transdermal body-identical formulations most commonly used today. Current evidence from large observational studies and re-analyses suggests that transdermal estrogen with micronised progesterone carries little to no additional breast cancer risk above baseline, and that for women who have had a hysterectomy, estrogen alone is associated with a reduced breast cancer risk. Describing unproven supplements as "the safer choice" is misleading when their safety profiles have not been studied at all.
Myth: Maca, ashwagandha, and adaptogens can rebalance hormones in menopause
Adaptogenic herbs — maca, ashwagandha, rhodiola, and others — are heavily promoted as a way to "rebalance" the hormonal system during menopause, often with the implication that they work on the endocrine system directly. The evidence for maca shows some modest improvements in self-reported mood and energy in small trials, but no confirmed effect on estrogen or FSH levels; ashwagandha has better evidence for stress and sleep but has not been shown to alter reproductive hormones meaningfully. Describing these herbs as hormone-balancing is a category error — they do not bind to estrogen receptors or replace declining ovarian output, and framing them as equivalents to hormone therapy sets unrealistic expectations.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.